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Objective: Temporomandibular joint (TMJ) diseases predominantly afﬂict women, suggesting a role for
female hormones in the disease process. However, little is known about the role of estrogen receptor (ER)
signaling in regulating mandibular condylar cartilage growth. Therefore, the goal of this study was to
examine the effects of altered estrogen levels on the mandibular condylar cartilage in wild type (WT) and
ER beta Knockout (KO) mice.
Materials and methods: 21-day-old female WT (n ¼ 37) and ER beta KO mice (n ¼ 36) were either sham
operated or ovariectomized, and treated with either placebo or estradiol. The mandibular condylar
cartilage was evaluated by histomorphometry, proliferation was analyzed by double ethynyl-20-deoxy-
uridine/bromodeoxyuridine (EdU/BrdU) labeling, and assays on gene and protein expression of chon-
drocyte maturation markers were performed.
Results: In WT mice, ovariectomy caused a signiﬁcant increase in mandibular condylar cartilage cell
numbers, a signiﬁcant increase in Sox9 expression and a signiﬁcant increase in proliferation compared
with sham operated WT mice. In contrast, ovariectomy did not cause any of these effects in the ER beta
KO mice. Estrogen replacement treatment in ovariectomized WT mice caused a signiﬁcant decrease in ER
alpha expression and a signiﬁcant increase in Sost expression compared with ovariectomized mice
treated with placebo. Estrogen replacement treatment in ovariectomized ER beta KO mice caused a
signiﬁcant increase in Col2 expression, no change in ER alpha expression, and a signiﬁcant increase in
Sost expression.
Conclusion: Estrogen via ER beta inhibits proliferation and ER alpha expression while estrogen inde-
pendent of ER beta induces Col2 and Sost expression.
© 2014 China University of Geosciences (Beijing) and Peking University. Published by Elsevier Ltd. All
rights reserved.Introduction
The mandibular condylar cartilage plays a central role in
craniofacial disorders such as mandibular growth abnormalities
(micrognathia or prognathia) and temporomandibular joint (TMJ)
degeneration, afﬂicting over 50 million Americans1,2. The
mandibular condylar cartilage differs from other articular cartilages
in that it undergoes endochondral ossiﬁcation, and robustly re-
models during growth to mechanical loading cues3. It is believed
that there are a ﬁnite number of mandibular condylar cartilage
progenitor cells; once the cells are depleted, repair remodeling and: S. Wadhwa, Division of Or-
dicine, New York, NY, USA.
).
eijing) and Peking University. Pubgrowth diminish in capacity. Like other joints, the TMJ degenerates
with age4,5. However, women between the ages of 44e55 years are
most likely to seek treatment6,7, suggesting a role for estrogen in
the disease process.
In long bones, estrogen is responsible for endochondral growth
plate fusion, in both males and females and the role of estrogen
receptors (ERs) in mediating long bone growth plate fusion has
been characterized8,9. For example, estrogen via the ER alpha is
responsible for growth plate fusion in both male and female mice8.
In contrast, ER beta is involved in growth inhibition in only young
female mice10. In fact, little is known about the role of estrogen and
ER signaling in the mandibular condylar cartilage. In our previous
study, we focused on the role of ER beta in regulating mandibular
condylar growth.We found that female ER beta knockout (KO)mice
had larger mandibular condylar cartilages, due to decreasedlished by Elsevier Ltd. All rights reserved.
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(WT) mice11. However, the role of estrogen in mediating these ef-
fects is not known. Therefore, the purpose of this study was to
characterize themandibular condylar cartilage phenotype of female
ER beta KO mice exposed to altered estrogen levels. A greater un-
derstanding of the role of ERs in regulating mandibular growth is
desperately needed in order to take best advantage of the promising
pharmacological advances provided by selective ERmodulators12 in
the treatment of mandibular growth abnormalities, and to under-
stand the etiology behind the sex predilection of TMJ degeneration.Material and methods
Mice
Breeding pairs of C57Bl/6 WT (Cat # 000664) and ERb KO mice
(homozygous male, heterozygous female, Cat # 004745) were pur-
chased from Jackson Labs. Homozygous ERb KO females were used
for the experiments. 21-day-old female C57Bl/6 WT (total n ¼ 37)
and ERb KO mice (total n ¼ 36) were sham-operated or ovariecto-
mized (OVX), and treated with placebo or 17b-estradiol for 28 days
at a dose of 10-ng/grambodyweight/day (60 day release, Innovative
Research of America, FL). Themicewere euthanized at 49days of age
(Table I for experiment design). This agewas chosenbecause the vast
majority of mandibular condylar cartilage growth in mice is com-
plete by 60 days of age13. Sixteen hours prior to euthanasia, themice
were injected intraperitoneally with 10-ug 5-ethynyl-20-deoxyur-
idine (EdU) per gram body weight. Three hours prior to euthanasia,
mice were injected intraperitoneally with 0.1 mg bromodeoxyur-
idine (BrdU) per gram body weight. All experiments were per-
formed in accordance with animal welfare based on an approved
Institutional animal care and use committee (IACUC) protocol
#AAAD0950 (fromtheColumbiaUniversityanimal care committee).RNA extraction and PCR ampliﬁcation
For each of the mice, the mandibular condylar heads (left and
right) containing both the mandibular condylar cartilage and sub-
chondral bonewere carefully harvested and all the soft tissueswere
removed under a dissecting microscope. Total RNA was obtained
from pooled left and right condylar heads and extractedwith TRIzol
Reagent (Invitrogen life technologies, Carlsbad, CA) following the
manufacturer's protocol. All mRNA sampleswere treatedwith DNA-
free DNase Treatment& Removal Kit (Ambion by Life Technologies)
to remove any possible DNA contamination. Total RNA was reverse
transcribed into cDNAusing the ABI High Capacity cDNA Archive KitTable I
Experimental Design for mice of WT and ER-beta KO.
Age of
mice
21-day old 49-day old
16 h prior
to euthanasia
3 h prior
to euthanasia
49-day old
Treatment Sham (WT, n ¼ 12;
KO, n ¼ 12)
Or
OVX-Placebo*
(WT, n ¼ 12; KO,
n ¼ 12)
Or
OVX-Estradiol*
(WT, n ¼ 13; KO,
n ¼ 12)
EdU injection BrdU injection Euthanasia
Abbreviation: OVX: ovariectomy.
* 17b-Estradiol (SE-121) and placebo (SC-111) pellets were products of Innova-
tive Research of America. The pellets were implanted under skin with a trochar and
are designed to release continuously for 60 days.(Applied Biosystems, Foster city, CA) following the manufacturer's
protocol. Real-Time polymerase chain reaction (PCR) gene expres-
sion for different genes was performed in separatewells (singleplex
assay) of a 96-well-plate, in a reaction volume of 20 ml. Gapdh was
used as endogenous control (Housekeeping gene, Applied Bio-
systems, Mm99999915_g1). Three replicates of each sample were
ampliﬁed using Assays-on-Demand Gene Expression for the
particular gene of interest and predesigned unlabeled gene-speciﬁc
PCR primers and TaqMan MGB Fluorescein amidite (FAM) dye-
labeled probes. The PCR reaction mixture (including 2X TaqMan
Universal PCR Master Mix, 20X Assays-on-Demand Gene Expres-
sionAssayMix, 50 ngof cDNA)was run in anApplied BiosystemsABI
Prism 7300 Sequence Detection System instrument utilizing uni-
versal thermal cycling parameters. For the genes for which the ef-
ﬁciencies of target and endogenous control ampliﬁcation were
approximately equal, relative expression of a test sample compared
to a reference calibrator sample (DDCt Method) was used for data
analysis. For the genes that were not ampliﬁed with the same efﬁ-
ciency as the endogenous control, the Relative Standard Curve
method, in which target quantity was determined from the stan-
dard curve and divided by the target quantity of the calibrator, was
used. Primers for Real-Time PCR were purchased from Applied
Biosystems. Gene expressionwas performed for SRY-box containing
gene 9 (Sox9dMm00448840_m1), collagen type II (Col2a1dMm
00491889_m1), collagen type X (Col10a1dMm00487041_m1), es-
trogen receptor alpha (Esr1dMm00433149_m1), sclerostin
(SostdMm00470479_m1), runt-related transcription factor
2(Runx2dMm00501578_m1), and dentin matrix acidic
phosphoprotein-1 (Dmp-1dMm00803833_g1).
Histology and immunohistochemistry
Wholemouse heads were sectioned into two halves, ﬁxed in 10%
formalin for 4 days at room temperature and decalciﬁed in 14%Fig. 1. Uterus weights (A) of 49-day-old, and Body weights (B) of 21- and 49-day-old
female WT and ER beta KO that were either sham-operated or ovariectomized and
treated with placebo or estradiol (10 ng/gram body weight/day) for 4 weeks.
n ¼ 12e13 mice for each age, genotype and treatment. Values are the means with
lower and upper limits of 95% CI. * ¼ signiﬁcant difference between Sham and OVX-
placebo groups. # ¼ signiﬁcant difference between OVX-placebo and OVX-estradiol
groups. In (A) WT, *P ¼ 0.004, #P ¼ 0.007; ER-beta KO, *and #P < 0.001. In (B) WT,
*P ¼ 0.005, #P ¼ 0.024; ER-beta KO, *P < 0.001, #P ¼ 0.004.
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MO) for 10 days (49 day samples). Subsequently, the samples were
processed through progressive concentrations of ethanol, cleared in
xylene, and embedded in parafﬁn. 5 mmsagittal serial sections of the
TMJwereperformedbyMicromHM355smicrotome (ThermoFisher
Scientiﬁc, Waltham, MA) and every ﬁfth section stained with H&E.
Histomorphometry measurements were made in a blinded,
nonbiased manner using the BioQuant computerized image anal-
ysis system (BioQuant, Nashville, TN). Mandibular condylar carti-
lage analysis was performed on H&E sagittal sections
corresponding to the mid-coronal portion of the mandibular
condylar head. The entire mandibular condylar cartilage area was
divided into three layers, superﬁcial layer (layer S), ﬂattened layer
(layer F), and hypertrophic layer (layer H) based on the cartilage cell
size, shape, and staining. The entire anterioreposterior condylar
cartilage area was measured for each section and the average of at
least three sections was taken for that mouse. Six to seven condyles
from each genotype and treatment groups were analyzed.
For immunohistochemistry, tissue sections were deparafﬁnized
with xylene and rehydrated with decreasing concentrations of
ethanol. Following rehydration, the sections were treated with 3%
peroxide to block endogenous peroxidase activity and digested for
60 minwith pepsin for unmasking (Lab Vision, Cat # AP-9007-006,
Fremont, CA). All sections were blocked with Protein Block Serum-
Free (DakoCytomation, code # X0909, Carpinteria, CA). Immuno-
histochemical staining was performed using the LSAB þ System-Fig. 2. H&E staining (A) and cell counts (B) of the mandibular condylar cartilage from 49-day
treated with either placebo or estradiol (10 ng/gram body weight/day). Cell counts were perf
and Upper Hypertrophic zone (H). The zones were delineated with black dashed lines. n
Bars ¼ 100 mm. In (B) values are the means with lower and upper limits of 95% CI. * ¼ sig
between OVX-placebo and OVX-estradiol groups. & ¼ signiﬁcant difference between Sham
*P ¼ 0.029, #P ¼ 0.021; H layer cell count, #P ¼ 0.005. In ER-beta KO total cell count, & P ¼HRP Kit (DakoCytomation, code # K0690) following the procedure
recommended by the manufacturer. The primary antibody used in
this study was collagen type II antigen (Millipore, MAB8887, 1:200
dilution). BrdU immunohistochemical analysis was completed us-
ing a BrdU staining kit following the manufacturer's instructions
(Zymed Laboratories-Invitrogen Corporation, Carlsbad, CA, USA).
EdU immunohistochemical analysis was completed using a Click-iT
EdU Alexa Fluor@488 Imaging Kit following the manufacturer's
instructions (Invitrogen, CA). Negative controls consisted of omit-
ting the primary antibody step and incubating with blocking so-
lution. To quantify BrdU and EdU staining, the labeling index
(number of BrdU or EdU positive cells/total number of cells) was
calculated. Three to ﬁve sections, corresponding to the same
anatomical area (mid sagittal), were counted for each condyle and
the average of these sections was taken as the labeling index.
Statistical analyses
Values are presented as the mean and 95% conﬁdence intervals
(CI) (lower and upper limits), with n ¼ number of mice. For RNA
analysis, RNAwas pooled from both left and right condyles from the
same mouse; however, one condyle from separate mice was
sectioned for histologic analysis. Normality of distribution was
conﬁrmed and statistical signiﬁcance of differences among means
was determined by one-way analysis of variance (ANOVA), with,
post hoc comparison of more than two means by the Bonferroni-old female WT and ER beta KO mice that were sham-operated or ovariectomized, and
ormed for the Superﬁcial Layer (S, Articular and Polymorphic zones), Flattened Zone (F)
¼ 6e8 for each age and genotype. All images were taken under 10 magniﬁcation.
niﬁcant difference between Sham and OVX-placebo groups. # ¼ signiﬁcant difference
and OVX-estradiol groups. In WT total cell count, * and #P ¼ 0.006; S layer cell count,
0.011; F layer cell count, * P ¼ 0.005, & P ¼ 0.004.
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niﬁcance was deﬁned as P < 0.05.
Results
In both the WT and ER beta KO mice, uterus weights were
signiﬁcantly decreased by ovariectomy and returned back to basal
levels by estrogen replacement therapy [Fig. 1(A)]. Ovariectomy
also caused a signiﬁcant increase in bodyweight in both 49-day-old
WT and ER beta KO mice [Fig. 1(B)].Fig. 3. EdU staining (A), BrdU staining (B) and Quantiﬁcation of EdU/BrdU labeling (C). Mice w
for BrdU and EdU was performed on the mandibular condyles of female 49-day-old WT a
placebo or estradiol (10 ng/gram body weight/day). (A) EdU positive cells were labeled with
under 10magniﬁcation. Bars ¼ 100 mm. (C) Labeling index ¼ number of positive EdU or Brd
genotype. Values are means with upper and lower limits of 95% CI. * signiﬁcant differenceOvariectomy caused an increase in mandibular condylar cartilage
growth in WT but not in ER beta KO mice
InWTmice, ovariectomycaused a signiﬁcant increase in total cell
numbers and in the number of cells in superﬁcial zone compared
with sham-operated WT mice. In contrast, ovariectomy in ER beta
KO mice caused a signiﬁcant decrease in the number of cells in the
ﬂattened zone compared with sham-operated ER beta KO mice.
Estradiol replacement treatment in ovariectomized WT mice
caused a signiﬁcant decrease in total cell numbers and a signiﬁcantere injected with EdU at 16 h and BrdU at 3 h prior to sacriﬁce. Immunohistochemistry
nd ERb KO mice that were sham-operated or ovariectomized, and treated with either
green ﬂuorescence. (B) BrdU positive cells were labeled brown. All images were taken
U/total number of cells was calculated for each of the groups. n ¼ 6e8 for each age and
(P ¼ 0.017) between WT Sham and OVX-placebo groups.
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zones compared with ovariectomized WT mice treated with pla-
cebo. Estradiol replacement treatment in ovariectomized ER beta
KO mice caused a signiﬁcant decrease in total cell numbers and a
decrease in the number of cells in the ﬂattened zone compared
with sham-operated ER beta KO mice (Fig. 2).Proliferation
There was a signiﬁcant increase in the percentage of EdU/BrdU
labeled cells in the ovariectomized WT mice, compared to sham
operated WT mice. However, no signiﬁcant difference in EdU/BrdU
labeling was evident in the ovariectomized ER beta KOmice treated
with placebo or estradiol (Fig. 3).Gene and protein expression
Ovariectomy caused a signiﬁcant increase in Sox9 expression,
compared with sham-operated WT mice. In ovariectomized WT
mice, estradiol replacement treatment caused a signiﬁcant
decrease in ER alpha expression, a signiﬁcant increase in Sost
expression, and no effect on Col2 expression, compared with
ovariectomized WT mice treated with placebo. In ovariectomized
ER beta KO mice, estradiol replacement treatment caused a sig-
niﬁcant increase in Col2 expression, no effect on ER alpha expres-
sion, and a signiﬁcant increase in Sost expression, compared with
ovariectomized ER beta KO mice treated with placebo (Fig. 4).
Altering the estrogen levels caused no signiﬁcant changes in the
expression of Col10, Runx2, and Dmp-1 in both ER beta KO andWT
mice (data not shown).Fig. 4. Quantiﬁcation of Sox9, Sost, ER Alpha, and Collagen type II (Col2) by Q-PCR was
performed on the mandibular condyles of 49-day-old female sham-operated or
ovariectomized WT and ERb KO mice treated with placebo or estradiol. (A) WT. (B) ERb
KO. n ¼ 6e8 for each age and genotype. Values are means with upper and lower limits
of 95% CI. * ¼ signiﬁcant difference between Sham and OVX-placebo groups.
# ¼ signiﬁcant difference between OVX-placebo and OVX-estradiol groups.
& ¼ signiﬁcant difference between Sham and OVX-estradiol groups. In (A), for Sox9,
*P ¼ 0.049; for Sost, #P ¼ 0.016, & P ¼ 0.015; for ER alpha, #P ¼ 0.018, & P ¼ 0.047. In
(B), for Sost, #P ¼ 0.026; for Col2, #P ¼ 0.013, & P ¼ 0.025.Immunohistochemistry for Collagen type 2 and Safranin O
staining revealed that estradiol replacement treatment resulted in
Col2 and Safranin O localization in the superior zones of the
mandibular condylar cartilages of ovariectomized ER Beta KO and
ovariectomized WT mice, compared with ovariectomized mice
treated with placebo (Fig. 5).
Discussion
Mandibular cartilage cell maturation proceeds through prolif-
eration and migration of Sox9-expressing progenitor cells, from the
polymorphic zone to the ﬂattened zone where they undergo
chondrogenesis. From there, they exit the proliferative pool and
enter the hypertrophic zone where they undergo terminal matu-
ration14. We found that, similar to other studies, estrogen deﬁ-
ciency caused increased mandibular condylar cartilage growth15,16.
In addition, we found that ovariectomy in WT mice resulted in an
increase in Sox9 expression and a signiﬁcant increase in prolifera-
tion, which were reversed by estradiol treatment. In contrast,
neither of these effects occurred in the ER beta KO mice. Taken
together, the results suggest that estrogen via the ER inhibits the
proliferation of Sox9 expressing cells.
In our previous study, we found that ER beta deﬁciency caused
an increase in mandibular condylar cartilage growth in female
mice11. In that same study, we found that female WT mice
expressed a relative decrease in the number of BrdU positive cells
when injected with BrdU at 16 h prior to sacriﬁce compared with
3 h prior to sacriﬁce inwhich the injections were performed on two
separate mice. This difference was not observed in the female ER
beta KOmice. In our current study, we intended to similarly analyze
proliferative pool exit by injecting EdU 16 h and BrdU 3 h prior to
sacriﬁce (BrdU) in the same mice. However, due to possible cell
cycle arrest caused by EdU injection17 and because the average
mandibular condylar cartilage cell cycle length is greater than
16 h18, we combined the EdU and BrdU data as a measure of pro-
liferation, as has been described in other studies10.
Gene expression analysis revealed that estradiol replacement
treatment caused a signiﬁcant increase in Col2 expression in
ovariectomized ER beta KO mice, and immunocytochemistry re-
sults indicated superior localization of Col2 in the mandibular
condylar cartilage in ovariectomized WT mice. Taken together, the
results suggest that the estradiol-induced increase in Col2 expres-
sion in the ER beta KO mice may be due to increased expression of
Col2 in ﬁbrocartilage cells. However, it remains to be determined
why there is a discrepancy between the mRNA data and the
immunocytochemistry results. During active growth, endochondral
ossiﬁcation occurs in the mandibular condylar cartilage and the
superﬁcial zones are devoid of Col2 expression. However, after the
cessation of mandibular condylar cartilage growth and the deple-
tion of polymorphic progenitor cells, the mandibular condylar
cartilage becomes phenotypically similar to other articular hyaline
cartilages and Col2 expression is detected throughout the
mandibular condylar cartilage19,20. Therefore, in the TMJ, estradiol-
induced superior localization of the Col2 may indicate accelerated
cartilage differentiation.
There are two main ERs, alpha and beta. Recent research, on
both humans and mice, has shown that growth plate fusion is
mediated by ER alpha8. Signaling interactions between ER beta and
ER alpha may explain why estradiol replacement treatment did not
cause a signiﬁcant increase in Col2 expression in the ovariecto-
mized WT mice. We found that estradiol treatment caused a sig-
niﬁcant decrease in ER alpha expression in WTmice. No such effect
on ER alpha expression was observed in the estradiol treated ER
beta KO mice, suggesting that ER beta signaling down regulates ER
alpha expression. In addition, ER beta deﬁcient osteoblastic cells
Fig. 5. Col2 Immunohistochemistry (A) and Safranin O staining (B) were performed on the mandibular condyles of 49-day-old female sham-operated or ovariectomized WT and
ERb KO mice treated with placebo or estradiol. In (A), the cartilage area was demarcated with black dashed line. All images were taken under 10 magniﬁcation. Bars ¼ 100 mm.
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average of 85%21, suggesting that ER beta inhibits ER alpha activity.
Future experiments are planned with ER alpha, ER beta and ER
alpha/beta Double Knockout (DKO) mice in order to delineate the
roles of ER alpha in regulating mandibular condylar cartilage
growth and chondrogenesis.
A possible mechanism for the increase in chondrogenesis
following estradiol treatment of the mandibular condylar cartilage
is the inhibition of canonical wnt signaling by Sost22. Studies have
shown that Sost is more highly expressed in the articular and
polymorphic zones than in the ﬂattened and hypertrophic zones of
mandibular condylar cartilage23. However, the increase in Sost may
also be due to increased expression in the subchondral bone. Future
experiments are planned in order to determine the localization of
estradiol-induced Sost expression in the TMJ. Since estradiol
treatment was found to increase Sost expression in both ER beta KO
and WT mice, we posit that Sost may be downstream of ER alpha
signaling. Studies have also shown that inhibition of canonical wnt
signaling inhibits proliferation24 and delays chondrocyte hyper-
trophy25. This may help explain why estradiol treatment in the
ovariectomized ER beta KO mice caused a decrease in the number
ﬂattened zone cells. The reason why ovariectomized ER beta KOalso had a decrease in the number of ﬂattened zone cells compared
to sham operated mice is unknown and is being further
investigated.
Similar to other joints, the TMJ degenerates with age, with over
70% of people between the ages of 73e75 showing signs of TMJ
degeneration4. Recent research has clearly dismissed the dogma
that women of childbearing age are most likely to suffer from TMJ
diseases; instead, it is most likely to occur in women between 35
and 54 years of age6,26,27. This new data may lead to a shift in the
role of estrogen in TMJ disease: from estrogen potentiating the
inﬂammation that occurs during TMJ disease28 to estrogen accel-
erating the disease process. This is in contrast to what typically
occurs in articular hyaline cartilages, where estrogen is believed to
have a protective effect on joint homeostasis29. This distinctionmay
be due to the fact that the mandibular condylar cartilage undergoes
endochondral ossiﬁcation during growth. We posit that the earlier
cessation of mandibular condylar cartilage growth in women, due
to estrogen, predisposes them to an increased likelihood of devel-
oping accelerated age-related TMJ degeneration. It is important to
note that our study was performed on young growing mice when
the bone and cartilage development was not complete, which does
not rule out the possibility that estrogen may have a different role
J. Chen et al. / Osteoarthritis and Cartilage 22 (2014) 1861e1868 1867in the TMJ of older non-growing mice. Future work is planned to
examine the effects of estrogen signaling in older mice.
In conclusion, we found that estrogen inhibits proliferation, via
an ER beta dependent mechanism, and regulates chondrogenesis,
independent of ER beta. A greater understanding of estrogen
signaling in the mandibular condyle is needed in order to develop
novel treatment modalities for patients with mandibular condylar
growth abnormalities and TMJ degeneration, and beneﬁt from
advances in selective ER modulator pharmacological therapies.
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